Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| CHCI | Holly Thomas Joseph | Director | 09/16/2026 | Zuteilung | — | 558 | — | Form 4 |
| CHCI | Paul David Peter | Director | 09/16/2026 | Zuteilung | — | 570 | — | Form 4 |
| CRBG | Nippon Life Insurance Co | 10% Owner | 09/16/2026 | Kauf | 35.02 | 320,785 | 11,232,960 | Form 4 |
| CSHR | Masters Daniel | Director | 09/16/2026 | Verkauf | 4.79 | 60,790 | 291,300 | Form 4 |
| CLNN | Matlin David J | Director | 09/16/2026 | Zuteilung | 3.28 | 434,451 | 1,424,999 | Form 4 |
| CLNN | Etherington Robert Dee | President & CEO | 09/16/2026 | Zuteilung | 3.28 | 15,244 | 50,000 | Form 4 |
| CLNN | Mosca Alison | Director | 09/16/2026 | Zuteilung | 3.28 | 198,171 | 650,001 | Form 4 |
| CLST | Kleiser Kirk E. | Director | 09/16/2026 | Optionsausübung | 13.30 | 16,928 | 225,142 | Form 4 |
| CLST | Kleiser Kirk E. | Director | 09/16/2026 | Optionsausübung | 12.08 | 529 | 6,390 | Form 4 |
| CBIO | Lynch Ryan | See Remarks | 09/16/2026 | Verkauf | 17.90 | 240 | 4,296 | Form 4 |
| CBIO | Pinkas Jan | Chief Scientific Officer | 09/16/2026 | Verkauf | 17.90 | 658 | 11,778 | Form 4 |
| CBIO | Im Ellie Eunkyung | Chief Medical Officer | 09/16/2026 | Verkauf | 17.90 | 623 | 11,152 | Form 4 |
| CBIO | Scalzo Richard William | Chief Financial Officer | 09/16/2026 | Verkauf | 17.90 | 568 | 10,167 | Form 4 |
| CBIO | Bispham Barbara Harlin | See Remarks | 09/16/2026 | Verkauf | 17.90 | 620 | 11,098 | Form 4 |
| CBIO | Brumm Joshua T | Chief Executive Officer | 09/16/2026 | Verkauf | 17.90 | 1,610 | 28,819 | Form 4 |
| CBIO | McNeill Jonathan | President and COO | 09/16/2026 | Verkauf | 17.90 | 731 | 13,085 | Form 4 |
| CORT | Vieira Roberto Wandenkolk | President, Oncology | 09/16/2026 | Verkauf | 100.82 | 296 | 29,843 | Form 4 |
| CL | Wallace Noel R. | Chairman, President & CEO | 09/16/2026 | Zuteilung | — | 29,649 | — | Form 4 |
| CL | Grant Shane | COO, Americas | 09/16/2026 | Zuteilung | — | 7,355 | — | Form 4 |
| CL | Tsourapas Panagiotis | COO, CD, EMEA, APac, Skin | 09/16/2026 | Zuteilung | — | 4,597 | — | Form 4 |
| CL | Sutula Stanley J Iii | Chief Financial Officer | 09/16/2026 | Zuteilung | — | 8,045 | — | Form 4 |
| CL | Hazlin John | Chief Growth Officer | 09/16/2026 | Zuteilung | — | 3,908 | — | Form 4 |
| CL | Massey Sally | Chief People Officer | 09/16/2026 | Zuteilung | — | 3,333 | — | Form 4 |
| CL | Fishbone Betsy | CLO and Secretary | 09/16/2026 | Zuteilung | — | 2,207 | — | Form 4 |
| CL | Malcolm Gregory | EVP and Controller | 09/16/2026 | Zuteilung | — | 1,081 | — | Form 4 |
| CSCO | Subaiya Thimaya K. | EVP, Operations | 09/16/2026 | Zuteilung | — | 55,690 | — | Form 4 |
| CSCO | Patel Jeetendra I | President and CPO | 09/16/2026 | Zuteilung | — | 139,225 | — | Form 4 |
| CSCO | Patterson Mark | EVP and CFO | 09/16/2026 | Zuteilung | — | 92,817 | — | Form 4 |
| CSCO | Robbins Charles | Chair and CEO | 09/16/2026 | Zuteilung | — | 167,069 | — | Form 4 |
| CSCO | Stahlkopf Deborah L | EVP and Chief Legal Officer | 09/16/2026 | Zuteilung | — | 55,690 | — | Form 4 |
| CSCO | Tuszik Oliver | EVP, Global Sales | 09/16/2026 | Zuteilung | — | 69,613 | — | Form 4 |
| CSCO | Fink Nichlas A | SVP, Chief Accounting Officer | 09/16/2026 | Zuteilung | — | 7,826 | — | Form 4 |
| CXM | Misra Amitabh | Chief Technology Officer | 09/16/2026 | Verkauf | 5.55 | 29,629 | 164,441 | Form 4 |
| CXM | Scott Jacob | GENERAL COUNSEL AND CORP. SEC. | 09/16/2026 | Verkauf | 5.55 | 26,094 | 144,822 | Form 4 |
| CXM | Thomas Ragy | Director | 09/16/2026 | Verkauf | 5.55 | 5,457 | 30,286 | Form 4 |
| CXM | Corso Joy | Chief Administrative Officer | 09/16/2026 | Verkauf | 5.55 | 34,153 | 189,549 | Form 4 |
| CXM | Macwan Sanjay | Chief Information Officer | 09/16/2026 | Verkauf | 5.55 | 6,936 | 38,495 | Form 4 |
| CXM | Read Rory P | President & CEO | 09/16/2026 | Verkauf | 5.55 | 145,865 | 809,551 | Form 4 |
| CRWD | Kurtz George | PRESIDENT AND CEO | 09/16/2026 | Verkauf | 244.90 | 173 | 42,368 | Form 4 |
| CRWD | Kurtz George | PRESIDENT AND CEO | 09/16/2026 | Verkauf | 244.12 | 527 | 128,651 | Form 4 |
| CRWD | Kurtz George | PRESIDENT AND CEO | 09/16/2026 | Verkauf | 243.13 | 1,223 | 297,348 | Form 4 |
| CRWD | Kurtz George | PRESIDENT AND CEO | 09/16/2026 | Verkauf | 242.16 | 1,953 | 472,938 | Form 4 |
| CRWD | Kurtz George | PRESIDENT AND CEO | 09/16/2026 | Verkauf | 241.23 | 3,332 | 803,778 | Form 4 |
| CRWD | Kurtz George | PRESIDENT AND CEO | 09/16/2026 | Verkauf | 240.11 | 1,394 | 334,713 | Form 4 |
| CRWD | Kurtz George | PRESIDENT AND CEO | 09/16/2026 | Verkauf | 239.20 | 855 | 204,516 | Form 4 |
| CRWD | Kurtz George | PRESIDENT AND CEO | 09/16/2026 | Verkauf | 364.26 | 354 | 128,948 | Form 4 |
| CRWD | Kurtz George | PRESIDENT AND CEO | 09/16/2026 | Verkauf | 236.32 | 189 | 44,664 | Form 4 |
| CRWD | Watzinger Gerhard | Director | 09/16/2026 | Verkauf | 241.45 | 767 | 185,192 | Form 4 |
| CRWD | Watzinger Gerhard | Director | 09/16/2026 | Verkauf | 240.87 | 8,244 | 1,985,732 | Form 4 |
| CRWD | Watzinger Gerhard | Director | 09/16/2026 | Verkauf | 239.88 | 27,918 | 6,696,970 | Form 4 |
| CRWD | Watzinger Gerhard | Director | 09/16/2026 | Verkauf | 238.98 | 35,299 | 8,435,755 | Form 4 |
| CRWD | Watzinger Gerhard | Director | 09/16/2026 | Verkauf | 237.99 | 21,792 | 5,186,278 | Form 4 |
| CRWD | Watzinger Gerhard | Director | 09/16/2026 | Verkauf | 236.30 | 25,980 | 6,139,074 | Form 4 |
| CRCT | Ashish Arora | Chief Executive Officer | 09/16/2026 | Verkauf | 5.55 | 60,000 | 333,264 | Form 4 |
| CTVA | Johnson David Paul | EVP, Chief Financial Officer | 09/16/2026 | Steuer-Abgabe | 81.01 | 8,517 | 689,962 | Form 4 |
| COR | Greenberg Lon R | Director | 09/16/2026 | Verkauf | 321.30 | 1,280 | 411,264 | Form 4 |
| COO | Kurzius Lawrence Erik | Director | 09/16/2026 | Kauf | 54.93 | 10,000 | 549,320 | Form 4 |
| CME | Marchese John Clifford | Sr MD, General Counsel | 09/16/2026 | Steuer-Abgabe | 272.46 | 44 | 11,988 | Form 4 |
| CME | McCourt Timothy Francis | Sr MD Global Head Equity & FX | 09/16/2026 | Steuer-Abgabe | 272.46 | 364 | 99,175 | Form 4 |
| CME | Fitzpatrick Lynne | President and CFO | 09/16/2026 | Steuer-Abgabe | 272.46 | 359 | 97,813 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).